MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, FEED had -$1,989K decrease in cash & cash equivalents over the period. -$4,329K in free cash flow.

Cash Flow Overview

Change in Cash
-$1,989K
Free Cash flow
-$4,329K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from the issuance of co...
    • Other accounts payable and accru...
    • Depreciation and amortization
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Repurchase of series x preferred...
    • Prepaid expenses and other accou...
    • Others

Cash Flow
2026-03-31
2025-12-31
Net loss
-3,822 -18,185
Depreciation and amortization
217 897
Noncash interest expense
30 239
Other
-19
Changes in deferred income taxes, net
--373
Change in fair value of warrant liability
-17 6,204
Impairment of goodwill and long-lived assets
-11,154
Issuance cost allocated to warrant liability
-1,420
Trade receivable
43 179
Prepaid expenses and other accounts receivable
943 96
Inventory
-71 -249
Trade payables
-13 552
Other accounts payable and accrued expenses
357 1,025
Deferred revenue
-175 160
Operating right-of-use asset
-11 -71
Operating lease liabilities
-19 -85
Accrued severance pay, net
--36
Net cash used in operating activities
-4,312 -9,372
Cash acquired in envue merger
-148
Purchase of property and equipment
17 60
Net cash (used in) provided by investing activities
-17 88
Proceeds from the issuance of common stock, preferred stock and warrants, net
3,900 19,089
Repurchase of series x preferred stock
1,560 5,000
Proceeds from issuance of notes payable to related party
-1,300
Payments of note payable to related party
-1,300
Payments of short-term loan to related party
-1,777
Proceeds from issuance of short-term loan payable
-360
Proceeds from exercise of warrants
-102
Other
-12
Net cash provided by financing activities
2,340 12,786
Net decrease in cash, cash equivalents and restricted cash
-1,989 3,502
Cash, cash equivalents and restricted cash at beginning of period
4,254 752
Cash, cash equivalents and restricted cash at end of period
2,265 4,254
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from theissuance of common stock,...$3,900K Net cash provided byfinancing activities$2,340K Canceled cashflow$1,560K Net decrease incash, cash...-$1,989K Canceled cashflow$2,340K Other accountspayable and accrued...$357K Depreciation andamortization$217K Inventory-$71K Noncash interestexpense$30K Change in fair value ofwarrant liability-$17K Operating right-of-useasset-$11K Repurchase of series xpreferred stock$1,560K Net cash used inoperating activities-$4,312K Canceled cashflow$703K Net cash (used in)provided by investing...-$17K Net loss-$3,822K Prepaid expenses andother accounts...$943K Deferred revenue-$175K Trade receivable$43K Operating leaseliabilities-$19K Trade payables-$13K Purchase of property andequipment$17K

ENvue Medical, Inc. (FEED)

ENvue Medical, Inc. (FEED)